A single-center analysis of genotype–phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing

Background: Autosomal dominant polycystic kidney disease (ADPKD) is mainly caused by PKD1 and PKD2 mutations. However, only a few studies have investigated the genotype and phenotype characteristics of Asian patients with ADPKD. This study aimed to investigate the relationship between the natural co...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in genetics 2022-09, Vol.13, p.934463-934463
Main Authors: Yan, Ziyan, Wang, Yuchen, Deng, Wenfeng, Zhou, Yi, Hu, Yangcheng, Qi, Ka, Liu, Ding, Xia, Renfei, Liu, Rumin, Zeng, Wenli, Zhang, Wei, Xu, Jian, Xiong, Fu, Miao, Yun
Format: Article
Language:English
Subjects:
autosomal dominant polycystic kidney disease
Genetics
mutation
PKD1
PKD2
TES using NGS
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Autosomal dominant polycystic kidney disease (ADPKD) is mainly caused by PKD1 and PKD2 mutations. However, only a few studies have investigated the genotype and phenotype characteristics of Asian patients with ADPKD. This study aimed to investigate the relationship between the natural course of ADPKD genotype and phenotype. Methods: Genetic studies of PKD1/2 genes of Chinese patients with ADPKD in a single center were performed using targeted exome sequencing and next-generation sequencing on peripheral blood DNA. Results: Among the 140 patients analyzed, 80.00% ( n = 112) harbored PKD1 mutations, 11.43% ( n = 16) harbored PKD2 mutations, and 8.57% ( n = 12) harbored neither PKD1 nor PKD2 mutations. The average age at dialysis was 52.60 ± 11.36, 60.67 ± 5.64, and 52.11 ± 14.63 years, respectively. The renal survival rate of ADPKD patients with PKD1 mutations (77/112) was significantly lower than that of those with PKD2 mutations (9/16), leading to an earlier onset of end-stage renal disease (ESRD). Renal prognosis was poor for those with nonsense mutations, and they required earlier renal replacement therapy. Conclusions: The genotype and phenotype characteristics of ADPKD patients potentially vary across ethnic groups. Our findings supplement the genetic profiles of Chinese ADPKD patients, could serve as a guide for therapy monitoring and prognosis assessment of ADPKD, and may improve the clinical diagnosis.
ISSN:1664-8021
1664-8021
DOI:10.3389/fgene.2022.934463